Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sernova Corp SEOVF


Primary Symbol: T.SVA

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:SVA)

Sernova Announces Key New Executive Appointments

TheNewsWire October 11, 2024

Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa

TheNewsWire October 3, 2024

Sernova Appoints David Paterson Ph.D. to its Board of Directors

TheNewsWire September 19, 2024

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function

GlobeNewswire September 12, 2024

Sernova to Participate in Upcoming H.C. Wainwright Investor Conference

TheNewsWire September 5, 2024

Sernova Closes $5.2 Million Over-Subscribed Non-Brokered, Private Placement

TheNewsWire September 4, 2024

Sernova Announces Oversubscribed Non-Brokered Private Placement

TheNewsWire August 29, 2024

Sernova Announces Up to $4 Million Private Placement Priced at a Premium

TheNewsWire August 20, 2024

Lead Investigator for Sernova's Clinical Trial with Cell Pouch for Type 1 Diabetes to Deliver Oral Presentation at the 2024 EASD Annual Meeting

TheNewsWire August 15, 2024
View More News ››

Opinion & Analysis (TSX:SVA)

Buzz on the Bullboards: 2021 The Year of the Cannabis Comeback?

Stockhouse Editorial February 11, 2021

Buzz on the Bullboards: When Stocks Go Up … Must They Come Down?

Stockhouse Editorial January 28, 2021

Buzz on the Bullboards: A Deeper Look into New Energy Opportunities

Stockhouse Editorial January 21, 2021

HemAcure and Sernova, a big deal

Richard (Rick) Mills July 25, 2017

Sernova, diabetes and haemophilia

Rick Rule July 25, 2016

Sernova (V.SVA) puts focus on diabetes treatment device

Stockhouse Editorial May 16, 2014
View More Opinion ››

Bullboard Posts (TSX:SVA)

loooking at this company it's been taking them years

to enroll patients and it takes years to get data to get fda or hpb in canada to see if they would approve this treatment which would...
edrose - 6 days ago

RE:RE:RE:this board

RixPix you are right it is very little.
palladium17 - 12 days ago

RE:RE:this board

Half a million shares shorted is nothing for SVA.  A Private Placement was done 2 months ago so having some shares shorted is...
rixpix - November 1, 2024

RE:this board

Hey WK. They've moved on, but not because they sold. They're all on another site. CEO . Ca.  Bioteck signed up as RixPix...
rixpix - November 1, 2024

RE:this board

Yep everyone has left this submarine except for the shorts.   Number of Shares Shorted Net Change ...
bbowles - October 29, 2024

this board

This board is no fun. Where did all the posters go from a couple of years ago? You know, the ones critisizing "spillup"...
woundedknee - October 29, 2024
View more Bullboard ››

Theralase Technologies Inc.

Theralase Technologies Inc.

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ...
View More »